health
Focus
  1. Software/AI for Healthcare and R&D
    Usable health-related data is increasing exponentially and creating vast opportunities for software and artificial intelligence to improve health outcomes in many components of healthcare including research, diagnostics, drug development, patient management, and backend support.
  2. Research Tools
    Basic scientific research tools such as DNA sequencing, spatial biology, and CRISPR fundamentally change the potential of innovation to benefit human health; investing in these advances has lasting impacts on subsequent technology advances and new medical treatments.
  3. Therapeutic Platforms
    Drug classes and modalities that can be applied to a variety of diseases benefit a greater target population and improve the economics of drug discovery. BEVC believes in the potential of next-generation drug types to have the greatest impact on patients’ lives.
  4. Biomanufacturing of Advanced Therapies
    As diagnostics and therapies become more complex, manufacturing presents rate-limiting technical challenges and costs if new paradigms are not developed. BEVC investment in biomanufacturing innovation will increase access and application of high-impact treatments such as Cell and Gene Therapy and personalized cancer vaccines through automation, decentralized manufacturing, and other innovations.
health advisors
David Schaffer, Ph.D.
David Schaffer, Ph.D.
Founding Advisor
view bio
Carolyn Bertozzi, Ph.D.
Carolyn Bertozzi, Ph.D.
Advisor
view bio
Christina Curtis, Ph.D., MSc
Christina Curtis, Ph.D., MSc
Advisor
view bio
Jennifer Doudna, Ph.D.
Jennifer Doudna, Ph.D.
Advisor
view bio
Regis Kelly, Ph.D., OBE
Regis Kelly, Ph.D., OBE
Advisor
view bio
Robert Tjian, Ph.D.
Robert Tjian, Ph.D.
Advisor
view bio
Greg Went, Ph.D.
Greg Went, Ph.D.
Advisor
view bio